Publications

Found 1 results
Filters: Author is S. Qiu  [Clear All Filters]
2013
L. He, Yao, H., Fan, L. H., Liu, L., Qiu, S., Li, X., Gao, J. P., and Hao, C. Q., MicroRNA-181b expression in prostate cancer tissues and its influence on the biological behavior of the prostate cancer cell line PC-3, vol. 12, pp. 1012-1021, 2013.
Ambros V and Chen X (2007). The regulation of genes and genomes by small RNAs. Development 134: 1635-1641. http://dx.doi.org/10.1242/dev.002006 PMid:17409118   Berezikov E, Guryev V, van de Belt J, Wienholds E, et al. (2005). Phylogenetic shadowing and computational identification of human microRNA genes. Cell 120: 21-24. http://dx.doi.org/10.1016/j.cell.2004.12.031 PMid:15652478   Chen C, Ridzon DA, Broomer AJ, Zhou Z, et al. (2005). Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Res. 33: e179. http://dx.doi.org/10.1093/nar/gni178 PMid:16314309 PMCid:1292995   Chen H, Chen Q, Fang M and Mi Y (2009). Regulatory effect on the proliferation of the leukemic cell HL-60 by miRNA- 181b through MLK2 science in China. Life Sci. 39: 1034-1040.   de Yébenes VG, Belver L, Pisano DG, Gonzalez S, et al. (2008). miR-181b negatively regulates activation-induced cytidine deaminase in B cells. J. Exp. Med. 205: 2199-2206. http://dx.doi.org/10.1084/jem.20080579 PMid:18762567 PMCid:2556787   Debernardi S, Skoulakis S, Molloy G, Chaplin T, et al. (2007). MicroRNA miR-181a correlates with morphological sub-class of acute myeloid leukaemia and the expression of its target genes in global genome-wide analysis. Leukemia 21: 912-916. PMid:17330104   Gibson W, Green A, Bullard RS, Eaddy AC, et al. (2007). Inhibition of PAX2 expression results in alternate cell death pathways in prostate cancer cells differing in p53 status. Cancer Lett. 248: 251-261. http://dx.doi.org/10.1016/j.canlet.2006.08.007 PMid:16996682   Jonler M and Pedersen KV (2007). Diagnosis, evaluation and follow-up of patients with prostatic cancer. Ugeskr. Laeger 169: 1889-1891. PMid:17553363   Livak KJ and Schmittgen TD (2001). Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25: 402-408. http://dx.doi.org/10.1006/meth.2001.1262 PMid:11846609   Marcucci G, Radmacher MD, Maharry K, Mrózek K, et al. (2008). MicroRNA expression in cytogenetically normal acute myeloid leukemia. N. Engl. J. Med. 358: 1919-1928. http://dx.doi.org/10.1056/NEJMoa074256 PMid:18450603   Meltzer PS (2005). Cancer genomics: small RNAs with big impacts. Nature 435: 745-746. http://dx.doi.org/10.1038/435745a PMid:15944682   Nakajima G, Hayashi K, Xi Y, Kudo K, et al. (2006). Non-coding MicroRNAs hsa-let-7g and hsa-miR-181b are associated with chemoresponse to S-1 in colon cancer. Cancer Genomics Proteomics 3: 317-324. PMid:18172508 PMCid:2170889   Ozen M, Creighton CJ, Ozdemir M and Ittmann M (2008). Widespread deregulation of microRNA expression in human prostate cancer. Oncogene 27: 1788-1793. http://dx.doi.org/10.1038/sj.onc.1210809 PMid:17891175   Pekarsky Y, Santanam U, Cimmino A, Palamarchuk A, et al. (2006). Tcl1 expression in chronic lymphocytic leukemia is regulated by miR-29 and miR-181. Cancer Res. 66: 11590-11593. http://dx.doi.org/10.1158/0008-5472.CAN-06-3613 PMid:17178851   Porkka KP, Pfeiffer MJ, Waltering KK, Vessella RL, et al. (2007). MicroRNA expression profiling in prostate cancer. Cancer Res. 67: 6130-6135. http://dx.doi.org/10.1158/0008-5472.CAN-07-0533 PMid:17616669   Prueitt RL, Yi M, Hudson RS, Wallace TA, et al. (2008). Expression of microRNAs and protein-coding genes associated with perineural invasion in prostate cancer. Prostate 68: 1152-1164. http://dx.doi.org/10.1002/pros.20786 PMid:18459106 PMCid:2597330   Rajewsky N (2006). microRNA target predictions in animals. Nat. Genet. 38 Suppl: S8-13. http://dx.doi.org/10.1038/ng1798 PMid:16736023   Schaefer A, Jung M, Mollenkopf HJ, Wagner I, et al. (2010). Diagnostic and prognostic implications of microRNA profiling in prostate carcinoma. Int. J. Cancer 126: 1166-1176. PMid:19676045   Shi L, Cheng Z, Zhang J, Li R, et al. (2008). hsa-mir-181a and hsa-mir-181b function as tumor suppressors in human glioma cells. Brain Res. 1236: 185-193. http://dx.doi.org/10.1016/j.brainres.2008.07.085 PMid:18710654   Spahn M, Kneitz S, Scholz CJ, Stenger N, et al. (2010). Expression of microRNA-221 is progressively reduced in aggressive prostate cancer and metastasis and predicts clinical recurrence. Int. J. Cancer 127: 394-403. PMid:19585579   Stark A, Brennecke J, Bushati N, Russell RB, et al. (2005). Animal MicroRNAs confer robustness to gene expression and have a significant impact on 3'UTR evolution. Cell 123: 1133-1146. http://dx.doi.org/10.1016/j.cell.2005.11.023 PMid:16337999   Volinia S, Calin GA, Liu CG, Ambs S, et al. (2006). A microRNA expression signature of human solid tumors defines cancer gene targets. Proc. Natl. Acad. Sci. U. S. A. 103: 2257-2261. http://dx.doi.org/10.1073/pnas.0510565103 PMid:16461460 PMCid:1413718   Xu L and Wang GM (2007). The progress and current situation in the management of moderate and far advanced prostate cancer. Int. J. Urol. Nephrol. 27: 773.   Zhang B and Farwell MA (2008). microRNAs: a new emerging class of players for disease diagnostics and gene therapy. J. Cell Mol. Med. 12: 3-21. http://dx.doi.org/10.1111/j.1582-4934.2007.00196.x PMid:18088390